Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Behjatolah Karbassi

Concepts (272)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antigens, Tumor-Associated, Carbohydrate
15
2023
24
3.690
Why?
Cancer Vaccines
13
2022
78
2.520
Why?
Peptides
17
2022
223
2.450
Why?
Carbohydrates
14
2009
41
2.280
Why?
Molecular Mimicry
13
2007
38
1.930
Why?
Breast Neoplasms
12
2024
1212
1.650
Why?
Neoplasms
9
2022
1325
1.410
Why?
Immunotherapy
6
2022
244
1.060
Why?
Epitopes, T-Lymphocyte
6
2009
26
0.860
Why?
HIV Envelope Protein gp120
4
2009
13
0.800
Why?
Antibodies, Neoplasm
2
2017
28
0.780
Why?
Lung Neoplasms
4
2014
636
0.780
Why?
HIV-1
4
2009
59
0.780
Why?
Mice, Inbred BALB C
16
2011
312
0.760
Why?
Antigens
4
2003
41
0.740
Why?
Animals
31
2023
13505
0.640
Why?
Epithelial-Mesenchymal Transition
2
2020
57
0.620
Why?
Clinical Trials, Phase I as Topic
2
2017
25
0.600
Why?
Gene Expression Regulation, Neoplastic
5
2020
857
0.590
Why?
Vaccines, DNA
6
2006
11
0.590
Why?
Immunologic Surveillance
2
2009
10
0.590
Why?
HIV Antigens
3
2006
9
0.560
Why?
Epitopes
3
2009
65
0.550
Why?
Cell Transformation, Neoplastic
1
2018
184
0.540
Why?
Antineoplastic Agents
3
2017
1222
0.510
Why?
Immunity, Innate
3
2018
117
0.510
Why?
Neoplasm Proteins
1
2018
334
0.490
Why?
Molecular Targeted Therapy
1
2017
133
0.490
Why?
Mice
20
2011
5949
0.490
Why?
Cell Hypoxia
1
2015
83
0.460
Why?
Biomimetic Materials
1
2014
11
0.460
Why?
Estrogen Receptor alpha
1
2015
85
0.460
Why?
Epigenesis, Genetic
1
2018
406
0.450
Why?
Vaccines
4
2002
51
0.430
Why?
T-Lymphocytes
7
2010
340
0.420
Why?
Cross Reactions
8
2006
41
0.420
Why?
Oligosaccharides
4
2007
34
0.420
Why?
Amino Acid Sequence
9
2006
578
0.420
Why?
Molecular Sequence Data
9
2006
778
0.410
Why?
Sarcoma, Experimental
2
2004
14
0.410
Why?
Antigens, Neoplasm
5
2007
147
0.410
Why?
Polysaccharides
2
2011
57
0.400
Why?
Humans
35
2024
52483
0.400
Why?
AIDS Vaccines
3
2009
11
0.390
Why?
Plant Lectins
2
2010
8
0.380
Why?
Isoflavones
1
2023
88
0.380
Why?
Sulfotransferases
3
2020
38
0.370
Why?
Chondroitin Sulfates
2
2011
15
0.360
Why?
P-Selectin
2
2011
30
0.360
Why?
Soybean Proteins
1
2023
162
0.360
Why?
CD8-Positive T-Lymphocytes
3
2007
132
0.350
Why?
Autoantigens
1
2011
53
0.350
Why?
Fructose
1
2010
22
0.350
Why?
Carbon
1
2010
55
0.340
Why?
Adaptive Immunity
1
2010
34
0.340
Why?
CD4-Positive T-Lymphocytes
3
2006
164
0.320
Why?
Vaccines, Subunit
3
2006
15
0.320
Why?
Obesity
2
2023
1162
0.320
Why?
Carcinoma, Ductal
1
2008
7
0.300
Why?
Drug Delivery Systems
1
2010
154
0.300
Why?
Proteoglycans
3
2023
87
0.290
Why?
Mammary Neoplasms, Experimental
2
2005
122
0.290
Why?
Interferon-gamma
4
2018
180
0.280
Why?
Carcinoma in Situ
1
2008
72
0.280
Why?
Cell Line, Tumor
6
2011
1470
0.280
Why?
Dendritic Cells
3
2005
136
0.270
Why?
T-Lymphocytes, Cytotoxic
5
2009
66
0.270
Why?
Female
18
2024
28171
0.260
Why?
Concanavalin A
2
2005
11
0.250
Why?
Sarcoma
1
2006
72
0.240
Why?
Mammary Neoplasms, Animal
1
2005
35
0.240
Why?
HIV Infections
1
2009
389
0.240
Why?
Ligands
5
2011
206
0.230
Why?
MCF-7 Cells
4
2020
64
0.230
Why?
Neoplasm Metastasis
5
2015
243
0.230
Why?
Magnetic Resonance Spectroscopy
1
2005
253
0.230
Why?
Acetylglucosamine
1
2004
7
0.220
Why?
Histocompatibility Antigens Class I
1
2004
48
0.220
Why?
Combined Modality Therapy
2
2017
639
0.210
Why?
Melanoma
1
2007
288
0.210
Why?
Immunoglobulin G
2
2003
195
0.210
Why?
Immunotherapy, Active
1
2003
4
0.210
Why?
Peptide Fragments
1
2004
203
0.210
Why?
Peptide Library
4
2005
16
0.200
Why?
Glycosylation
3
2010
106
0.200
Why?
Autoantibodies
2
2018
121
0.200
Why?
Cell Proliferation
4
2020
1023
0.200
Why?
Antigens, Viral
1
2002
43
0.190
Why?
Apoptosis
2
2020
1119
0.190
Why?
Antibodies, Monoclonal
5
2023
481
0.190
Why?
Biochemistry
1
2001
6
0.180
Why?
Enzyme-Linked Immunosorbent Assay
3
2010
235
0.180
Why?
Liver Neoplasms
1
2005
333
0.180
Why?
Cell Adhesion
3
2006
163
0.170
Why?
Carbamates
1
2020
16
0.170
Why?
CHO Cells
3
2006
125
0.170
Why?
Cricetinae
3
2006
194
0.170
Why?
Adjuvants, Immunologic
2
2014
52
0.170
Why?
Colchicine
1
2020
24
0.170
Why?
Antineoplastic Agents, Phytogenic
1
2020
71
0.160
Why?
Carcinoma, Ductal, Breast
1
2020
90
0.160
Why?
Neoplastic Stem Cells
1
2020
99
0.160
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2020
91
0.150
Why?
Anthroposophy
1
2018
1
0.150
Why?
Tumor Microenvironment
2
2024
256
0.150
Why?
Tumor Cells, Cultured
3
2015
460
0.150
Why?
Antibody Formation
3
2003
51
0.150
Why?
Cell Division
3
2006
291
0.150
Why?
Gene-Environment Interaction
1
2018
40
0.150
Why?
Immunization
3
2004
69
0.140
Why?
Chondroitin Sulfate Proteoglycans
2
2023
18
0.140
Why?
Immune Tolerance
2
2009
91
0.140
Why?
Plant Extracts
1
2020
194
0.140
Why?
Flow Cytometry
3
2006
478
0.140
Why?
Cell Movement
4
2020
268
0.140
Why?
Spleen
3
2004
172
0.140
Why?
Homeostasis
1
2018
201
0.130
Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.130
Why?
Forecasting
1
2017
154
0.130
Why?
HIV Antibodies
2
2006
15
0.130
Why?
Models, Immunological
2
2007
8
0.120
Why?
Membrane Proteins
2
2023
335
0.120
Why?
Interleukin-12
2
2006
27
0.120
Why?
Lectins
2
2006
14
0.120
Why?
Phenotype
2
2010
789
0.120
Why?
Coculture Techniques
1
2015
144
0.120
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2015
59
0.120
Why?
Drug Therapy
1
2014
44
0.110
Why?
Transforming Growth Factor beta
1
2015
138
0.110
Why?
Antibodies
1
2014
159
0.110
Why?
Adipocytes
1
2015
132
0.110
Why?
Vaccines, Conjugate
2
2005
9
0.110
Why?
Nuclear Proteins
1
2015
245
0.110
Why?
Cell Separation
2
2005
83
0.100
Why?
Scavenger Receptors, Class E
1
2015
204
0.100
Why?
Rats, Zucker
1
2023
73
0.100
Why?
Positron-Emission Tomography
1
2014
301
0.100
Why?
Cytotoxicity, Immunologic
2
2005
58
0.100
Why?
Protein Binding
2
2005
667
0.100
Why?
Immunity, Cellular
2
2003
64
0.100
Why?
Mutation
1
2018
1347
0.100
Why?
Mice, Nude
2
2004
265
0.100
Why?
Lymphocyte Activation
3
2001
172
0.100
Why?
C-Reactive Protein
1
2023
155
0.090
Why?
Kinetics
2
2005
626
0.090
Why?
Injections, Intramuscular
2
2003
56
0.090
Why?
Interleukin-6
1
2023
278
0.090
Why?
Binding Sites
2
2003
377
0.090
Why?
Prognosis
3
2020
2099
0.090
Why?
Tumor Necrosis Factor-alpha
1
2023
399
0.090
Why?
Microscopy, Phase-Contrast
1
2010
13
0.090
Why?
Body Weight
1
2023
523
0.090
Why?
Lung
1
2014
509
0.090
Why?
Transfection
3
2007
357
0.090
Why?
B-Lymphocytes
2
2002
184
0.090
Why?
DNA Methylation
1
2015
592
0.090
Why?
Antigens, CD
2
2003
218
0.080
Why?
Substrate Specificity
1
2010
193
0.080
Why?
Membrane Glycoproteins
2
2003
244
0.080
Why?
Actins
1
2010
115
0.080
Why?
Dose-Response Relationship, Drug
2
2005
1378
0.080
Why?
Antibodies, Catalytic
1
2009
1
0.080
Why?
Receptors, CCR5
1
2009
7
0.080
Why?
Neoplasm Invasiveness
1
2010
278
0.080
Why?
Cells, Cultured
2
2003
1567
0.080
Why?
Time Factors
2
2005
2968
0.080
Why?
Killer Cells, Natural
1
2009
116
0.070
Why?
Fucosyltransferases
1
2007
5
0.070
Why?
Glycosaminoglycans
1
2007
19
0.070
Why?
Male
3
2023
26761
0.070
Why?
Molecular Biology
1
2007
27
0.070
Why?
Binding Sites, Antibody
1
2006
15
0.070
Why?
Rats
1
2023
3220
0.070
Why?
Amino Acid Motifs
1
2006
57
0.070
Why?
Heparin
1
2007
88
0.060
Why?
Cricetulus
1
2006
104
0.060
Why?
Cell Membrane
1
2007
245
0.060
Why?
Antineoplastic Agents, Alkylating
1
2006
77
0.060
Why?
E-Selectin
1
2005
13
0.060
Why?
Xenograft Model Antitumor Assays
1
2006
220
0.060
Why?
Cyclophosphamide
1
2006
171
0.060
Why?
Wheat Germ Agglutinins
1
2005
3
0.060
Why?
Densitometry
1
2005
13
0.060
Why?
Mannose
1
2005
16
0.060
Why?
Hydrocarbons
1
2005
14
0.060
Why?
Surface Plasmon Resonance
1
2005
23
0.060
Why?
Methane
1
2005
11
0.060
Why?
Phosphorylcholine
1
2005
20
0.060
Why?
Bone Marrow Cells
1
2006
190
0.060
Why?
Growth Inhibitors
1
2005
26
0.060
Why?
Biosensing Techniques
1
2005
30
0.060
Why?
Calcium
1
2007
376
0.060
Why?
Immunoglobulins
1
2005
76
0.060
Why?
Glycolysis
1
2005
73
0.060
Why?
Genetic Variation
1
2006
230
0.060
Why?
Oligonucleotide Array Sequence Analysis
1
2006
405
0.060
Why?
Antigen Presentation
1
2004
26
0.060
Why?
Endothelial Cells
1
2006
262
0.060
Why?
Cytosol
1
2004
80
0.050
Why?
Bone Neoplasms
1
2006
184
0.050
Why?
Treatment Outcome
1
2014
5422
0.050
Why?
Immunoglobulin Constant Regions
1
2003
3
0.050
Why?
Plasmids
2
2003
163
0.050
Why?
Recombinant Proteins
1
2005
483
0.050
Why?
Middle Aged
2
2020
13028
0.050
Why?
Histocompatibility Antigens Class II
1
2003
36
0.050
Why?
Antibodies, Viral
1
2003
109
0.050
Why?
Bacterial Capsules
1
2003
19
0.050
Why?
DNA, Neoplasm
1
2003
146
0.050
Why?
Immunoglobulin M
1
2003
60
0.050
Why?
Th1 Cells
1
2003
55
0.050
Why?
Carbohydrate Metabolism
1
2002
23
0.050
Why?
Antibodies, Anti-Idiotypic
1
2002
25
0.050
Why?
Models, Chemical
1
2002
66
0.050
Why?
L-Selectin
1
2001
7
0.050
Why?
Calorimetry
1
2001
6
0.050
Why?
Carbohydrate Sequence
1
2001
10
0.050
Why?
Epitope Mapping
1
2001
7
0.050
Why?
Thermodynamics
1
2001
35
0.050
Why?
Binding, Competitive
1
2001
90
0.050
Why?
Mice, Inbred CBA
1
2001
37
0.050
Why?
Protein Structure, Secondary
1
2001
71
0.050
Why?
Sequence Homology, Amino Acid
1
2001
140
0.040
Why?
Gene Expression Profiling
1
2006
1105
0.040
Why?
Protein Conformation
1
2001
176
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
1
2000
12
0.040
Why?
Injections, Intraperitoneal
1
2000
57
0.040
Why?
Colchicum
1
2020
3
0.040
Why?
Inhibitory Concentration 50
1
2020
74
0.040
Why?
Models, Molecular
1
2001
348
0.040
Why?
Drug Screening Assays, Antitumor
1
2020
136
0.040
Why?
H-2 Antigens
1
1999
4
0.040
Why?
Wnt Signaling Pathway
1
2020
94
0.040
Why?
Receptors, Estrogen
1
2020
131
0.040
Why?
Child, Preschool
1
2008
4076
0.040
Why?
Transformation, Genetic
1
1998
17
0.040
Why?
Glycoside Hydrolases
1
1998
18
0.040
Why?
Clostridium
1
1998
17
0.040
Why?
Cell Survival
1
2020
612
0.040
Why?
Genes, Reporter
1
1998
88
0.040
Why?
Plants
1
1998
30
0.040
Why?
Models, Biological
1
2001
735
0.040
Why?
Survival Rate
1
2020
945
0.030
Why?
Adolescent
1
2008
6739
0.030
Why?
Retrospective Studies
1
2008
6607
0.030
Why?
Child
1
2008
7248
0.030
Why?
CpG Islands
1
2015
121
0.030
Why?
Disease Progression
1
2015
871
0.020
Why?
RNA Interference
1
2011
181
0.020
Why?
RNA, Small Interfering
1
2011
213
0.020
Why?
Lymphocyte Subsets
1
2003
14
0.010
Why?
Simian virus 40
1
2003
14
0.010
Why?
Immunoglobulin Variable Region
1
2003
17
0.010
Why?
Mutagenesis, Site-Directed
1
2003
95
0.010
Why?
Sequence Deletion
1
2003
73
0.010
Why?
Protein Structure, Tertiary
1
2003
242
0.010
Why?
Recombinant Fusion Proteins
1
2003
177
0.010
Why?
Down-Regulation
1
2003
346
0.010
Why?
Up-Regulation
1
2003
454
0.010
Why?
HIV Envelope Protein gp160
1
1999
2
0.010
Why?
Radiation Chimera
1
1999
4
0.010
Why?
beta 2-Microglobulin
1
1999
39
0.010
Why?
Protein Engineering
1
1999
20
0.010
Why?
Plants, Toxic
1
1998
10
0.010
Why?
Enzyme Stability
1
1998
21
0.010
Why?
Plants, Genetically Modified
1
1998
19
0.010
Why?
Stem Cells
1
1999
177
0.010
Why?
Hot Temperature
1
1998
214
0.010
Why?
Signal Transduction
1
2003
1671
0.010
Why?
Mice, Knockout
1
1999
879
0.010
Why?
Mice, Inbred C57BL
1
1999
1884
0.010
Why?
Muscle, Skeletal
1
1999
804
0.010
Why?
Karbassi's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description